Cigna Group Faces Sector Challenges Amid Rising Costs and Mixed Market Signals
Cigna Group navigates rising medical costs, specialty drug expenses, and mixed trading signals as analysts maintain a positive outlook amid sector-wide challenges.
U.S. Prescription Drug Denials by Private Insurers Increase 25% from 2016 to 2023
Analysis shows a 25% increase in U.S. private insurer prescription drug denials from 2016-2023, driven by rising drug costs and claim automation. Insights into industry impact and reform efforts.
U.S. Sees 25% Rise in Drug Denials; Sarepta Gene Therapy Deaths; Medicaid Data Access for ICE
Prescription drug denials by private insurers rise 25% (2016-2023). Sarepta gene therapy linked to patient deaths. ICE gains Medicaid data access. ACA insurers seek 2026 rate hikes. Implications for U.S. insurance, regulatory compliance, and patient access.
Maris Kreizman on Publishing Industry Challenges and Freelance Writing Realities
Maris Kreizman shares insights on the evolving U.S. publishing industry, freelance writing challenges, health insurance issues for creatives, and critiques of corporate media structures.
Study Shows Insurance Status Affects Survival Gains from Immune Checkpoint Inhibitors in Cancer
Research reveals immune checkpoint inhibitors improve cancer survival rates but widen insurance-based disparities. Expanding health coverage may mitigate gaps in treatment outcomes.
Alaska Enacts SB 133 to Expedite and Enhance Health Insurance Prior Authorizations
Alaska's SB 133 mandates 72-hour decision deadlines for health insurance authorizations, increases transparency, and protects patients with chronic conditions, effective 2027.
Avoiding Lifetime Penalties in Medicare Part D Enrollment
Learn how to avoid lifetime Medicare Part D penalties by timely enrollment, understanding creditable coverage, and utilizing Extra Help financial assistance programs.
Humana’s Medicare Advantage Legal Setback Highlights Shifting CMS Regulatory Landscape
Humana's legal loss against CMS over Medicare Advantage star ratings underscores structural regulatory risks reshaping insurer margins and strategies in the U.S. Medicare Advantage market.
Debate: Should the U.S. Government Offer Public Health Insurance Competition?
A detailed debate on the proposal for a U.S. government health insurance plan competing with private insurers, highlighting key perspectives from experts Jacob Hacker and David Goldhill.
Kentucky Insurance and Financial Legislation Advances Consumer Protections and Innovation
Kentucky's 2023 legislation enhances insurance innovation, consumer protections, and financial sector regulations, including expanded insurance sandboxes and improved health and automobile insurance standards.